Screener/Healthcare/Biotechnology

VKTX

Viking Therapeutics, Inc.NASDAQ
$33.18+0.93 (+2.89%)
Mid CapUnder $50HealthcareGLP-1 / Weight Loss
$18.92
$43.15
$32.48
$33.44
EPS (TTM)$-3.19
P/E Ratio—
Dividend Yield—
Market Cap$3.76B
Volume205K
Prev Close$32.17
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$0-$157.7M$-1.39——
Q3 '25$0-$90.8M$-0.81——
Q2 '25$0-$65.6M$-0.58——
Q1 '25$0-$45.6M$-0.41——
Q4 '24$0-$35.4M$-0.32——
Q3 '24$0-$24.9M$-0.22——
Q2 '24$0-$22.3M$-0.20——
Q1 '24$0-$27.4M$-0.26——
Get Your Daily Market Recap